Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Docetaxel trihydrate 20 mg in 0.5 mL, 80 mg in 2 mL; plus 13% w/w ethanol 95% in water for injection 1.5 mL and 6 mL (solvent) Concentrate for infusion (vials), solvent (vials) Rhone-Poulenc Rorer SA., Vitry sur Seine, France and Rhone-Poulenc Rorer Limited, Dagenham, Essex, United Kingdom Taxotere Note: This provisional consent is valid for 2 years from the date of publication of this notice. Dated this 14th day of May 1996. HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.